Return to List
Study Summary
No.
HNS97-121:
.......
Oropharynx
......
Ann M. Gillenwater
......
Head/Neck Surgery
.
Study Summary Title
Study Summary
Number:
HNS97-121
Study Title:
Evaluation of Native Tissue Autofluorescence Properties of Oral Mucosa Using Fluorescence Spectroscopy in Subjects without a History of Oral Cavity Neoplasia
.
Physician
New Patient Referral
Name:
Ann M. Gillenwater
Patients Call:
800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:
Head/Neck Surgery
Referring MD
Call:
800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:
713-792-8841
Contact us about clinical trials
.
General Information
Disease Group:
Oropharynx
Supported By:
National Institue of Dental Research-Oral Cavity Center of Excellence
Phase of Study:
N/A
Return
Visit:
none
Treatment
Agents:
Fluorescence Spectroscopy
Home Care:
none
Treatment Loc:
Only at MDACC
Estimated
Length of Stay
in Houston:
none
Description/
Intervention:
The goal of this clinical research study is to test a new way to look for
cancer and pre-cancerous tissue changes inside the mouth.
.
Study Objectives / Outcomes
The overall objective of this study is to obtain background data on the native tissue autoflourescence of oral mucosa in the normal population using fluorescence and reflectance spectroscopy.
.
Study Status Information
Study Activation / Registration Date:
07/25/1997
IRB Review and Approval Date:
07/20/2009
Study Type:
Other
Recruitment Status:
Open
Projected Accrual:
N/A
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you.
Please Contact the
Referral Office
for more information.
Inclusion Criteria:
1) Family members accompany patients and staff at the UTMDACC clinics
Exclusion Criteria:
1) Persons with previous SCCs of the oral cavity, radiation therapy to the head and neck region, chemotherapy within the previous six months use of smokeless tobacco, or current oral cavity lesions will be excluded.
.
Links
Registration Number:
Not Applicable Clinical Trial
Other Links:
.
Results
Return to Clinical Trials at M.D. Anderson Cancer Center